Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- Nasdaq ends down as chipmakers fall and bank earnings roll in
- Oil prices settle mixed, focus on US-Russia diesel deal, Saudi Yemen attacks
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Fed’s Waller says US bond yield rise driven by growth, not inflation
- Wells Fargo beats profit estimates despite revenue miss
| CHIMERIX (NASDAQ: CMRX) | Delayed: 8.54 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.54 | 52 Week High | $42.24 | |||
| Open | $8.54 | 52 Week Low | $3.50 | |||
| Day High | $8.54 | P/E | N/A | |||
| Day Low | $8.54 | EPS | $-0.47 | |||
| Volume | 112,000 | |||||
| JAZZ PHARMACEUTICAL (NASDAQ: JAZZ) | Delayed: 210.39 -6.36 (2.93%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $216.75 | 52 Week High | $160.00 | |||
| Open | $216.86 | 52 Week Low | $95.80 | |||
| Day High | $216.86 | P/E | 39.11 | |||
| Day Low | $209.34 | EPS | $5.38 | |||
| Volume | 812,642 | |||||
